Table 1.

Characteristics of Donors Infected with HIV-1

Donor	Plasma CD4+ cells (count/μL)	Plasma HIV-1 RNA (copies/mL)	Duration of HIV-1 infection (years)	Co-infections	ARV	Cause of death	P24+ cells in SV⁎
85	NA	139,000	NA	HCV	NA	AIDS	2.20
108	<20	51,681	NA	HCV/HBV	Combivir, Sustiva	AIDS	0.24
111	134	<50	NA	HCV	Atripla	Lymphoma	0
	1 month†	1 month†
110	219	<50	17	None	Oxanadol, Itellence, Prezista, Viread, Isentress, Norvir	End-stage renal disease	0.12
	1 week†	1 week† (for 4 years)
112	256	<50	26	HBV	Tenofovir, Epivir, Abacavir, Trizivir	Liver cancer	0.97
	1 month†	1 month†
103	269	<50 (for 5 years)	NA	HCV/HBV/HTLV	Tenofovir, Sustiva, Ziagen, Epivir	Nephropathy	0.61
107	437	<50	17	HCV/HBV	Epzicom, Reyataz, Norvir	Respiratory failure due to pneumonia	0.04
	1 day†	1.5 month† (previous AIDS)
139	495	<50	20	None	Atripla	Myocardial infarction	0
	2 months†	4 months†
92	1076	<50	NA	HCV/HBV	Truvada (stopped 1 week before death)	Adenocarcinoma	0.74
	2 months†	4 months†

ARV, antiretroviral drugs; HBV, hepatitis B virus; HCV, hepatitis C virus; HTLV, human T cell leukemia virus; NA, not available; SV, seminal vesicles.

^⁎Number of cells/mm².

^†Time of measurement before death.